KR100926326B1 - 여드름 치료 방법 - Google Patents

여드름 치료 방법 Download PDF

Info

Publication number
KR100926326B1
KR100926326B1 KR1020037012965A KR20037012965A KR100926326B1 KR 100926326 B1 KR100926326 B1 KR 100926326B1 KR 1020037012965 A KR1020037012965 A KR 1020037012965A KR 20037012965 A KR20037012965 A KR 20037012965A KR 100926326 B1 KR100926326 B1 KR 100926326B1
Authority
KR
South Korea
Prior art keywords
acne
hydrogen
doxycycline
administered
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020037012965A
Other languages
English (en)
Korean (ko)
Other versions
KR20040007488A (ko
Inventor
로버트 에이. 애슐리
Original Assignee
콜라제넥스 파마슈티칼스, 인크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23079310&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100926326(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 콜라제넥스 파마슈티칼스, 인크 filed Critical 콜라제넥스 파마슈티칼스, 인크
Publication of KR20040007488A publication Critical patent/KR20040007488A/ko
Application granted granted Critical
Publication of KR100926326B1 publication Critical patent/KR100926326B1/ko
Assigned to 갈더마 라보라토리즈 인코포레이티드 reassignment 갈더마 라보라토리즈 인코포레이티드 권리의 전부이전등록 Assignors: 콜라제넥스 파마슈티칼스, 인크
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020037012965A 2001-04-05 2002-04-05 여드름 치료 방법 Expired - Lifetime KR100926326B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28191601P 2001-04-05 2001-04-05
US60/281,916 2001-04-05
PCT/US2002/010747 WO2002080932A1 (en) 2001-04-05 2002-04-05 Methods of treating acne

Publications (2)

Publication Number Publication Date
KR20040007488A KR20040007488A (ko) 2004-01-24
KR100926326B1 true KR100926326B1 (ko) 2009-11-12

Family

ID=23079310

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037012965A Expired - Lifetime KR100926326B1 (ko) 2001-04-05 2002-04-05 여드름 치료 방법

Country Status (12)

Country Link
EP (4) EP1383508B1 (https=)
JP (3) JP2004536046A (https=)
KR (1) KR100926326B1 (https=)
AT (1) ATE330615T1 (https=)
AU (1) AU2002303250B2 (https=)
CA (2) CA2719162C (https=)
DE (1) DE60212613T2 (https=)
DK (1) DK1383508T3 (https=)
ES (1) ES2266499T3 (https=)
NZ (1) NZ528197A (https=)
PT (1) PT1383508E (https=)
WO (1) WO2002080932A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2311799A1 (en) * 2002-01-08 2011-04-20 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US8192749B2 (en) 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
ES2534827T3 (es) 2003-04-07 2015-04-29 Supernus Pharmaceuticals, Inc. Formulaciones de tetraciclinas en dosis única diaria
CN103040773A (zh) 2003-07-25 2013-04-17 沃纳奇尔科特有限责任公司 多西环素金属络合物固体剂型
NZ547628A (en) * 2003-11-06 2010-07-30 Univ New York State Res Found Methods of treating eczema
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7704959B2 (en) * 2006-10-03 2010-04-27 Dow Pharmaceutical Sciences Azithromycin for the treatment of nodular acne
AU2008231033B2 (en) * 2007-03-23 2012-08-30 Molecular Research Center, Inc. Anti-inflammatory compositions comprising tetracyclines and use thereof in therapy
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
WO2009138516A1 (en) * 2008-05-16 2009-11-19 Galderma Research & Development Therapy regimen for treating acne related diseases
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
BR112014025980A2 (pt) * 2012-04-19 2018-04-17 Galderma Sa método para o tratamento da acne
RU2557991C1 (ru) * 2014-05-19 2015-07-27 Вячеслав Владимирович Чеботарёв Способ лечения больных вульгарными угрями (акне), страдающих дисплазией соединительной ткани
CO2017001953A1 (es) * 2017-02-27 2018-08-31 Corporacion Univ Lasallista Método de encapsulación de tetraciclinas
CN111343991A (zh) * 2017-07-21 2020-06-26 阿尔米雷尔有限责任公司 非炎性病变的治疗
CN111818927A (zh) 2018-01-07 2020-10-23 雷迪博士实验室有限公司 用于治疗炎性皮肤疾病的米诺环素
CA3125456A1 (en) * 2019-01-04 2020-07-09 Dermata Therapeutics, Llc Compositions and methods for the treatment of skin conditions
WO2021215405A1 (ja) * 2020-04-20 2021-10-28 国立大学法人大阪大学 免疫賦活化剤、及び治療又は予防用組成物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122519A (en) * 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
JP3170277B2 (ja) * 1990-08-16 2001-05-28 マーチン，ネイル・エフ 眼瞼炎の局所治療
US5674539A (en) * 1994-12-09 1997-10-07 Tomas; Robert E. Method of treating skin and composition
FR2730930B1 (fr) * 1995-02-27 1997-04-04 Oreal Utilisation d'inhibiteurs de no-synthase pour diminuer l'effet irritant cutane de produits utilises dans le domaine cosmetique ou pharmaceutique
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6015804A (en) * 1998-09-11 2000-01-18 The Research Foundation Of State University Of New York Method of using tetracycline compounds to enhance interleukin-10 production
KR20010073190A (ko) * 1998-09-28 2001-07-31 제임스 알. 데니히 백내장 형성 억제제
US5998390A (en) * 1998-09-28 1999-12-07 The Research Foundation Of State University Of New York Combination of bisphosphonate and tetracycline
ATE336238T1 (de) * 1998-11-18 2006-09-15 Collagenex Pharm Inc Neue 4-dedimethylaminotetracyclinderivate
JP2001072660A (ja) * 1999-09-08 2001-03-21 Welfide Corp ＴＮＦ−α産生抑制剤および／またはＩＬ−１０産生促進剤

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000628A1 (en) * 1981-08-27 1983-03-03 Bernstein, Joel, E. A method of treating acne vulgaris and composition containing carbamide peroxide

Also Published As

Publication number Publication date
PT1383508E (pt) 2006-11-30
EP1716856A2 (en) 2006-11-02
DK1383508T3 (da) 2006-12-27
EP2221056A1 (en) 2010-08-25
DE60212613T2 (de) 2007-05-24
EP1383508B1 (en) 2006-06-21
EP1712236A3 (en) 2008-05-28
EP1383508A1 (en) 2004-01-28
ES2266499T3 (es) 2007-03-01
NZ528197A (en) 2007-04-27
CA2440472C (en) 2011-01-18
KR20040007488A (ko) 2004-01-24
EP1716856A3 (en) 2009-02-18
CA2440472A1 (en) 2002-10-17
DE60212613D1 (de) 2006-08-03
JP2011168613A (ja) 2011-09-01
WO2002080932A1 (en) 2002-10-17
ATE330615T1 (de) 2006-07-15
JP2010053155A (ja) 2010-03-11
CA2719162C (en) 2014-12-23
EP1712236A2 (en) 2006-10-18
JP2004536046A (ja) 2004-12-02
EP1383508A4 (en) 2005-07-06
AU2002303250B2 (en) 2006-05-25
CA2719162A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
KR100926326B1 (ko) 여드름 치료 방법
US10058564B2 (en) Methods of treating acne
US7008631B2 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
AU2002303250A1 (en) Methods of treating acne
US20120220555A1 (en) Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea
KR20050007553A (ko) 알레르기 반응을 치료하는 방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20031002

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070316

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080214

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20090506

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20090828

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20091104

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20091105

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20121019

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20121019

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20131017

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20131017

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20141021

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20141021

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20151012

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20151012

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20160929

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20160929

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20181018

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20181018

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20201015

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20211015

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20221005

Termination category: Expiration of duration